General information and entertainment, not investment advice. The author is not a SEBI-registered adviser or research analyst. No recommendation, no promised returns. Markets carry risk including loss of capital. Figures may not be current. Consult a registered adviser before acting.
1. Opening Hook
Srivasavi just crossed ₹110 crore in revenue—its highest ever—and immediately declared it a “peak investment year.” Translation: the topline flexed while the bottom line held its breath. The company added five manufacturing units in a single financial year, invested ₹17+ crore in capex, and cheerfully announced it’s running three of them at 50% utilization. That’s the shape of the story: growth on the headline, margin pressure underneath, and a ₹10.58 crore capital work-in-progress queue waiting to turn into operating loss.
2. At a Glance
| Metric | Reality Check |
|---|---|
| Revenue | ₹109.98 Cr (+22% YoY). Highest topline ever. Unspectacular growth rate for a capacity play. |
| Profit After Tax | ₹6.01 Cr vs ₹6.80 Cr last year (−12% YoY). The growth didn’t reach the bottom line. |
| Operating Margin | 8.46% (down from 10% last year). Capacity added; margins compressed. |
| Cost of Raw Materials | ₹83.08 Cr (up from ~₹75 Cr). Input cost ate 75% of revenue. |
| Finance Cost | ₹47 lakh (up from 28 lakh). Borrowings rose to fund expansion. |
| Debt | ₹17.9 Cr (long-term + short-term). Debt-to-equity: 0.38. Modest, but climbing. |
| Depreciation | ₹1.43 Cr (up from 1.1 Cr). New assets, not yet producing returns. |
| Capital Work in Progress | ₹10.58 Cr (Unit 5 polymer division + Unit 6 on the horizon). Revenue-generating capacity: zero. |
3. Management’s Key Commentary
On the investment thesis:
“We deliberately chose to invest ahead of our demands.” — D N Anilkumara
(Translation: We built capacity betting the market would follow. Units 3 and 4 are at 50%. Betting still ongoing.)
On backward integration:
“Our backward integration and in-house pressure-sensitive adhesive and sealants developing polymer division is what let us compete in that import substitute opportunity.” — D N Anilkumara
(Translation: We’re making our own adhesives so we don’t have to buy them from Korea and Japan. Sounds strategic. Costs ₹10 crore and won’t generate revenue until FY27-28.)
On the defense PSU win:
“We are supplying to ammunition factory, parachute factories, and electronics BEL.” — D N Anilkumara
(Translation: We’ve entered the high-barrier defense supply chain. Scale? Unquantified. Timeline? “Years to come.”)
On margin timeline:
“I’m precisely aiming this year for double-digit margins. I will try to achieve that.” — D N Anilkumara
(Translation: Margins sat at 8.46% last year. Aiming higher. No math on how, or when.)
On working capital:
“Minimum 75 days. It goes up to 100, 100 also sometimes, because all OEM customers.” — D N Anilkumara
(Translation: OEMs tie up our cash for 3+ months. That’s structural, not negotiable.)
On the ₹2.58 crore acquisition that is now worth ₹20 crore:
“Today’s value is somewhere around 20 crores. We got around 10% price only.” — D N Anilkumara
(Translation: Management bought used equipment from a bank auction. The bargain of the year—if it works.)
4. Numbers Decoded
| Line Item | FY26 | FY25 | Change | The Number Speaks |
|---|---|---|---|---|
| Revenue from Operations | ₹109.98 Cr | ₹90.16 Cr | +22% | 22% growth. Call it healthy for a small-cap. Not transformational. |
| Cost of Raw Materials | ₹83.08 Cr | ~₹75 Cr (est.) | +₹8 Cr | Raw material inflation ate 75% of revenue. Passthrough lag baked in. |
| Employee Costs | (not itemized) | (not itemized) | — | Workforce up from 280 to 357 (+28% headcount). Cost inflation not yet visible in P&L. |
| Finance Cost | ₹47 lakh | ₹28 lakh | +₹19 lakh | Borrowings up ₹16+ crore. Interest burden mild (₹47 lakh on ₹17.9 Cr debt = 2.6% blended rate). |
| Depreciation | ₹1.43 Cr | ₹1.1 Cr | +₹33 lakh | ₹19.56 Cr in tangible assets added. Depreciation drag will climb as new units run. |
| Operating Profit (EBITDA proxy) | ~₹9.5 Cr | ~₹10 Cr | −5% | OPM 8.46% vs 10% last year. Margin squeeze is real. |
| Profit After Tax | ₹6.01 Cr | ₹6.80 Cr | −12% | Revenue +22%, profit −12%. The gulf tells the story. |
| EPS (Basic) | ₹4.24 | ₹4.80 | −12% | Same trajectory as PAT. No earnings per share improvement. |
| Fixed Assets | ₹23 Cr | ₹15 Cr | +₹8 Cr | Asset base swelled. Depreciation load will follow. |
| CWIP | ₹10.58 Cr | ₹0 Cr | +₹10.58 Cr | Unit 5 (polymer) + Unit 6 (leased, solar-powered) under construction. Timeline: Unit 5 by FY27-28; Unit 6 ~4 months to production. |
| Total Debt | ₹17.9 Cr | ₹1 Cr | +₹16.9 Cr | Debt-to-equity 0.38. Leverage climbed sharply to fund capex. Still modest vs peers, but trajectory notable. |
| Net Worth | ₹46.71 Cr | ₹33 Cr | +₹13.7 Cr | IPO proceeds of ~₹15 Cr deployed. Equity base strengthened. |
5. Analyst Questions
Q: How much market share does China and Korea hold?
Management: “Market is already flooded with Chinese, Korean, and Japanese. We’re increasing backward integration.”
(Decode: Competitors are entrenched. No share data given. Management’s answer is a pivot to cost structure, not market conquest.)
Q: Can you quantify aerospace revenue?
Management: “About 4% roughly. Margins are double digits—more than double digits. I don’t want to explain.”
(Decode: ₹4.4 Cr of ₹109.98 Cr topline. Margin secret-kept. That’s either ≥20% (juicy) or a negotiating position.)
Q: What will Unit 6 capex be?
Management: “Not yet finalized. Broadly we already covered. If required, it may be about within the five range.”
(Decode: ₹5 crore, maybe. Unfinalized. Solar power will “cover our rental.” Math unshown.)
Q: What’s the order book?
Management: “All our customer plans. We don’t get a single order in a single day. Rolling over as per their projections. Somewhere around 160 to 175.”
(Decode: ₹160–175 Cr in rolling annual orders. Execution expected in FY27. No binding contracts. Customer guidance, not binding orders.)
Q: If crude price stays high, how long does margin compression last?
Management: “We can compress at least two, three months. No problem.”
(Decode: Raw material passthrough lag is 2–3 months in the worst case. Then prices reset. Assumes customer acceptance of price hikes—not guaranteed.)
6. Guidance & Outlook
Management guided for ₹160–175 crore in rolling annual orders for FY27—pending customer execution. No revenue guidance. No margin target (management said it “aims for double digit,” but provided no timeline or math). Unit 5 polymer division targeted to go live by FY27-28, with ₹10 crore invested. Unit 6 expected to start production in “four months” (from June, ~October), with capex to be finalized, possibly ₹5 crore. Export presence planned but not detailed (“we’ll give the clarification very soon”). Capacity ceiling assumed at ₹85–90 crore under current infrastructure; higher figures require capex or “mindset” changes undefined.
7. Risks & Red Flags
- Capacity Utilization: Units 1–2 at 60–70%; Units 3–4 at 50%; Units 5–6 not yet operational. The company is building ahead of demand. If demand plateaus, fixed cost per unit rises and margins compress further.
- Raw Material Passthrough Lag: 75% of revenue is raw materials. Passthrough to customers takes 2–3 months and is partial (management gets 15–25% of the hike, not 100%). In a sustained high-cost environment, margin pressure persists.
- Debt Climb: Debt jumped from ₹1 Cr to ₹17.9 Cr in one year. Debt-to-equity is 0.38 (modest), but trajectory is steep. Further capex will push this higher unless profitability accelerates sharply.
- Working Capital Drag: 92 debtor days + 87 inventory days − 76 payable days = 102 days cash conversion cycle. OEM customers hold cash for 3+ months. As revenue scales, working capital needs scale linearly.
- Unproven New Segments: Defense PSU orders are nascent (scale undefined). EMS ramp-up just beginning. Polymer backward integration won’t produce revenue until FY28. Risk: CapEx spent, demand doesn’t materialize at expected volumes or margins.
- Margin Recovery Assumption: Management targets double-digit OPM. Current: 8.46%. No breakdown on cost savings or volume leverage. Risk: margin recovery lags capacity absorption.
8. Badi Badi Baatein, Vadapao Khate; Will Management Walk the Talk?
The promises:
- “1,000 crore revenue by 2030-ish” (unspecified timeline, four-pillar plan: backward integration, capacity expansion, sector diversification, export scale-up).
- “Double-digit operating margins” (current 8.46%; management “aiming” but no roadmap).
- “Defense PSU and EMS ramp-up” (foundational, not revenue-generating yet).
The track record:
- FY24 to FY25: Revenue ₹78 Cr → ₹90 Cr (+15%). Profit ₹5 Cr → ₹7 Cr (+40%). Margins held at ~10%.
- FY25 to FY26: Revenue ₹90 Cr → ₹110 Cr (+22%). Profit ₹7 Cr → ₹6 Cr (−12%). Margins fell to 8.46%.
The pattern is clear: revenue is scaling (14% CAGR over 5 years; 22% TTM). Profitability stumbled in FY26 due to heavy capex and input cost inflation. Management’s credibility rests on whether the new capacity (Units 3–6) and new segments (defense, EMS, backward integration) turn into incremental profit by FY28–29. The company has invested ₹17+ crore ahead of demand. If execution slips, margins remain compressed and the ₹16.9 crore debt burden weighs harder.
9. EduInvesting Take
Strengths:
- Topline scaling consistently (₹14 Cr CAGR over 5 years, 22% TTM).
- Operating in a high-barrier sector (speciality adhesives, certifications from defense, railways, EMS).
- Backward integration (polymer division, adhesive manufacturing in-house) is a long-term margin and de-risking play.
- Debt modest relative to equity (0.38 D/E).
- Order visibility into FY27 (₹160–175 Cr rolling annual projections).
Weaknesses:
- Profit contracted 12% YoY despite 22% revenue growth. Margin compression is not transient; it’s structural to the capex phase.
- New capacity (Units 3–6) running well below full utilization. Absorption will take time.
- Working capital drag worsening (102-day cycle, driven by OEM payment terms).
- Raw material passthrough incomplete; company absorbs 75–85% of input cost hikes, mitigating ~15–25% to customers.
- New revenue streams (defense, EMS, polymer) are early-stage, unproven, and multi-quarter journeys.
What to watch next quarter:
- Unit 3 and Unit 4 utilization rates (are they climbing toward 60–70%?).
- Aerospace revenue (currently 4% of topline; margin profile).
- Defense PSU order ramp and customer diversification.
- EMS ramp-up scale and approval timelines.
- Polymer division (Unit 5) capex spend and FY27-28 launch readiness.
- Raw material cost trends and pricing actions (passthrough percentage).
- Debt levels and further capex requirements (Unit 6 finalization).
- Operating margin recovery trajectory (path to double digits).
10. Conclusion
Srivasavi is mid-capex cycle: topline stretching (₹110 Cr, +22%), profits shrinking (₹6 Cr, −12%), and management doubling down on capacity and certification. The numbers show a company betting on three things—polymer backward integration, defense-grade OEM orders, and EMS ramp—to justify ₹27+ crore in capex (CWIP + recent asset adds). If these bets land and capacity utilization climbs to 70%+, margins rebound to double digits and the ₹1,000 crore vision becomes plausible. If demand stalls or passthrough remains incomplete, the fixed cost per unit rises and profitability stays pinched. The ordeal isn’t resolved until Unit 5 and Unit 6 are online and pulling revenue. Until then, growth on the topline masks contraction on the bottom line.
Written by EduInvesting Team
Sources: Srivasavi Adhesive Tapes FY26 Earnings Conference Call transcript (June 10, 2026); Screener financial data (standalone consolidated P&L, balance sheet, cash flow, ratios — March 2014 to March 2026).